arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Tectonic Therapeutic, Inc.

TECX

$30.92 ▲ +0.66 (+2.16%) at close

10 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Tectonic Therapeutic, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $566.5M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -34.0% ↘

FCF / Share $-3.29 ↗

Trailing P/E —

Price / Book 2.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-74.15M

↓ -27.9% —

FCF / Share Free cash flow per share

$-3.29

↑ +52.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality →

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2016

FY 2017

FY 2018

FY 2019

FY 2020

FY 2021

FY 2022

FY 2023

$0.00

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
EPS Growth YoY (%)	40.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	12.9% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-27.9% Weak Weak Year-over-year change in net income	N/M	N/M	11.1% Fair ↑ Fair Improving Year-over-year change in net income	0.5% Caution ↑ Caution Improving Year-over-year change in net income	-64.1% Weak ↑ Weak Improving Year-over-year change in net income	-57.4% Weak Weak Year-over-year change in net income	-148.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	52.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-159.4% Weak Weak Year-over-year change in free cash flow	36.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Effective Tax Rate (%) (%)	-1.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-5.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-34.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	8.5% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-110.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-32.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	62.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-32.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	10.1% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-101.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-261.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-29.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-297%)	-41.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-375%)	12.8% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	-140.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1037%)	-70.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-569%)	-47.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-414%)	-39.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-362%)	-37.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-353%)	80.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+437%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Interest Coverage (x)	—	-542.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	5.32x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	-58.32x Weak Weak Operating income divided by interest expense Optimal: > 5x	-585.42x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	$-253.80M	$-141.24M	$-98.02M	$-92.56M	$-189.57M	$-259.68M	$-187.04M	$-126.30M	$-5.96M	—

📊 What does each share earn? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Basic EPS, GAAP (USD)	$-4.05	$-6.83	$0.51	$-4.57	$-5.25	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.29	$-6.98	$-2.69	$-4.20	—	—	—	—	—	—
Dividend per Share (USD)	$0.00	$0.00	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$13.41	$9.48	$4.00	$3.24	$7.33	$10.99	$11.09	$9.68	$-18.94	—
Tangible Book Value per Share (USD)	$13.41	$9.48	$4.00	$3.24	$7.33	$10.99	$11.09	$9.68	$-18.94	—
Basic Weighted Avg Shares (shares)	18.32M	8.49M	23.49M	23.18M	22,713	—	—	—	—	—
Dividend Payout Ratio (%)	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$247.69M	$135.25M	$93.91M	$86.84M	$179.76M	$250.63M	$181.68M	$119.41M	$3.68M	—
Total Equity (USD)	$251.33M	$140.78M	$94.74M	$75.37M	$169.48M	$254.34M	$186.01M	$122.18M	$-23.14M	$-4.58M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Depreciation Expense (USD)	$1.38M	$1.65M	$617.00K	$1.44M	$1.40M	$1.21M	$850.00K	$380.00K	$45.00K	—
Net Income, GAAP (USD)	$-74.15M	$-57.98M	$12.16M	$-105.89M	$-119.13M	$-119.71M	$-72.97M	$-46.36M	$-18.65M	—
Operating Cash Flow (USD)	$-60.08M	$-59.08M	$-63.19M	$-97.21M	$-98.03M	$-98.80M	$-67.67M	$-37.65M	$-16.38M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters

Tectonic Therapeutic, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TECX with peers